Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.

Igawa S, Ono T, Kasajima M, Ishihara M, Hiyoshi Y, Kusuhara S, Nishinarita N, Fukui T, Kubota M, Sasaki J, Hisashi M, Yokoba M, Katagiri M, Naoki K.

Cancer Manag Res. 2019 May 28;11:4883-4892. doi: 10.2147/CMAR.S207170. eCollection 2019.

2.

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.

Shirasawa M, Fukui T, Kusuhara S, Harada S, Nishinarita N, Hiyoshi Y, Ishihara M, Kasajima M, Igawa S, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Naoki K.

PLoS One. 2019 Apr 19;14(4):e0214599. doi: 10.1371/journal.pone.0214599. eCollection 2019.

3.

Postoperative pulmonary function changes according to the resected lobe: a 1-year follow-up study of lobectomized patients.

Yokoba M, Ichikawa T, Harada S, Naito M, Sato Y, Katagiri M.

J Thorac Dis. 2018 Dec;10(12):6891-6902. doi: 10.21037/jtd.2018.11.108.

4.

Questionnaire survey on patient awareness of invasive rebiopsy in advanced non-small cell lung cancer.

Fukui T, Ishihara M, Kasajima M, Hiyoshi Y, Nakahara Y, Otani S, Igawa S, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Naoki K.

Thorac Cancer. 2019 Mar;10(3):501-507. doi: 10.1111/1759-7714.12964. Epub 2019 Jan 16.

5.

Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.

Igawa S, Nishinarita N, Takakura A, Ozawa T, Harada S, Kusuhara S, Niwa H, Hosotani S, Sone H, Nakahara Y, Fukui T, Mitsufuji H, Yokoba M, Kubota M, Katagiri M, Sasaki J, Naoki K.

Cancer Manag Res. 2018 Dec 14;10:7013-7019. doi: 10.2147/CMAR.S189556. eCollection 2018.

6.

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer.

Shirasawa M, Fukui T, Kusuhara S, Hiyoshi Y, Ishihara M, Kasajima M, Nakahara Y, Otani S, Igawa S, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Naoki K.

Cancer Manag Res. 2018 Nov 21;10:6039-6047. doi: 10.2147/CMAR.S181789. eCollection 2018.

7.

Genioglossus muscle activity during sniff and reverse sniff in healthy men.

Ichikawa T, Yokoba M, Kimura M, Shibuya M, Easton PA, Katagiri M.

Exp Physiol. 2018 Dec;103(12):1656-1665. doi: 10.1113/EP086995. Epub 2018 Oct 17.

PMID:
30242925
8.

Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma.

Nakahara Y, Fukui T, Shirasawa M, Harada S, Kusuhara S, Takakura A, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Masuda N, Inukai M, Sekiguchi T, Naoki K.

Intern Med. 2018 Nov 1;57(21):3149-3152. doi: 10.2169/internalmedicine.9884-17. Epub 2018 Jun 6.

9.

Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations.

Nishinarita N, Igawa S, Kasajima M, Kusuhara S, Harada S, Okuma Y, Sugita K, Ozawa T, Fukui T, Mitsufuji H, Yokoba M, Katagiri M, Kubota M, Sasaki J, Naoki K.

Oncology. 2018;95(2):109-115. doi: 10.1159/000488594. Epub 2018 Apr 26.

PMID:
29698957
10.

Oxidative stress increases megalin expression in the renal proximal tubules during the normoalbuminuric stage of diabetes mellitus.

Kurosaki Y, Imoto A, Kawakami F, Yokoba M, Takenaka T, Ichikawa T, Katagiri M, Ishii N.

Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F462-F470. doi: 10.1152/ajprenal.00108.2017. Epub 2017 Nov 29.

11.

Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease.

Niwa H, Nakahara Y, Yokoba M, Mitsufuji H, Sasaki J, Masuda N.

Mol Clin Oncol. 2017 Oct;7(4):604-608. doi: 10.3892/mco.2017.1359. Epub 2017 Aug 3.

12.

Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status.

Ishihara M, Igawa S, Sasaki J, Otani S, Fukui T, Ryuge S, Katono K, Hiyoshi Y, Kasajima M, Mitsufuji H, Kubota M, Yokoba M, Katagiri M, Sekiguchi A, Soda I, Ishiyama H, Hayakawa K, Masuda N.

Oncol Lett. 2017 Jul;14(1):885-890. doi: 10.3892/ol.2017.6231. Epub 2017 May 23.

13.

A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis.

Tokura S, Akira M, Okuma T, Tazawa R, Arai T, Sugimoto C, Matsumuro A, Hirose M, Takada T, Nakata K, Ishii H, Kasahara Y, Hojo M, Ohkouchi S, Tsuchihashi Y, Yokoba M, Eda R, Nakayama H, Nei T, Morimoto K, Nasuhara Y, Ebina M, Ichiwata T, Tatsumi K, Yamaguchi E, Inoue Y.

Ann Am Thorac Soc. 2017 Sep;14(9):1403-1411. doi: 10.1513/AnnalsATS.201607-574OC.

PMID:
28489417
14.

Correlation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer.

Kasajima M, Igawa S, Ishihara M, Otani S, Takakura A, Yokoba M, Kubota M, Sasaki J, Katagiri M, Masuda N.

Oncol Lett. 2017 Mar;13(3):1719-1724. doi: 10.3892/ol.2017.5662. Epub 2017 Feb 1.

15.

Corrigendum to "Aminophylline increases respiratory muscle activity during hypercapnia in humans" [Pulm. Pharmacol. Ther. (2015) 96-101].

Yokoba M, Ichikawa T, Takakura A, Ishii N, Kurosaki Y, Yamada Y, Tsukushi T, Masuda N, Easton PA, Katagiri M.

Pulm Pharmacol Ther. 2016 Dec;41:103. doi: 10.1016/j.pupt.2016.09.009. Epub 2016 Sep 28. No abstract available.

PMID:
27692698
16.

Endobronchial involvement of mantle cell lymphoma: A case report.

Katono K, Shirasawa M, Harada S, Niwa H, Nakahara Y, Igawa S, Yokoba M, Kubota M, Masuda N.

Respir Med Case Rep. 2016 Jul 19;19:77-9. doi: 10.1016/j.rmcr.2016.07.012. eCollection 2016.

17.

Parasternal intercostal and diaphragm function during sleep.

Yokoba M, Hawes HG, Kieser TM, Katagiri M, Easton PA.

J Appl Physiol (1985). 2016 Jul 1;121(1):59-65. doi: 10.1152/japplphysiol.00508.2015. Epub 2016 Apr 28.

18.

Phase I and pharmacokinetic study of erlotinib administered in combination with amrubicin in patients with previously treated, advanced non-small cell lung cancer.

Otani S, Hamada A, Sasaki J, Wada M, Yamamoto M, Ryuge S, Takakura A, Fukui T, Yokoba M, Mitsufuji H, Toyooka I, Maki S, Kimura M, Hayashi N, Ishihara M, Kasajima M, Hiyoshi Y, Katono K, Asakuma M, Igawa S, Kubota M, Katagiri M, Saito H, Masuda N.

Am J Clin Oncol. 2015 Aug;38(4):405-10. doi: 10.1097/COC.0b013e3182a2d98d.

PMID:
26214085
19.

Aminophylline increases respiratory muscle activity during hypercapnia in humans.

Yokoba M, Katagiri M, Ichikawa T, Takakura A, Ishii N, Kurosaki Y, Yamada Y, Tsukushi T, Masuda N, Easton PA, Nishii Y, Okada Y, Abe T.

Pulm Pharmacol Ther. 2015 Feb;30:96-101. doi: 10.1016/j.pupt.2014.03.006. Epub 2014 Apr 8.

PMID:
24721495
20.

Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.

Tazawa R, Inoue Y, Arai T, Takada T, Kasahara Y, Hojo M, Ohkouchi S, Tsuchihashi Y, Yokoba M, Eda R, Nakayama H, Ishii H, Nei T, Morimoto K, Nasuhara Y, Ebina M, Akira M, Ichiwata T, Tatsumi K, Yamaguchi E, Nakata K.

Chest. 2014 Apr;145(4):729-737. doi: 10.1378/chest.13-0603.

PMID:
24158247
21.

Angiotensin-converting enzyme inhibition curbs tyrosine nitration of mitochondrial proteins in the renal cortex during the early stage of diabetes mellitus in rats.

Ishii N, Carmines PK, Yokoba M, Imaizumi H, Ichikawa T, Ikenagasa H, Kodera Y, Oh-Ishi M, Aoki Y, Maeda T, Takenaka T, Katagiri M.

Clin Sci (Lond). 2013 Apr;124(8):543-52. doi: 10.1042/CS20120251.

22.

Rapid deconjugation of SN-38 glucuronide and adsorption of released free SN-38 by intestinal microorganisms in rat.

Takakura A, Kurita A, Asahara T, Yokoba M, Yamamoto M, Ryuge S, Igawa S, Yasuzawa Y, Sasaki J, Kobayashi H, Masuda N.

Oncol Lett. 2012 Mar;3(3):520-524. Epub 2011 Dec 9.

23.

Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.

Asakuma M, Yamamoto M, Wada M, Ryuge S, Katono K, Yokoba M, Fukui T, Takakura A, Otani S, Maki S, Igawa S, Yanaihara T, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Masuda N.

Cancer Chemother Pharmacol. 2012 Jun;69(6):1529-36. doi: 10.1007/s00280-012-1858-2. Epub 2012 Mar 14.

PMID:
22415148
24.

Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.

Ohashi K, Sato A, Takada T, Arai T, Kasahara Y, Hojo M, Nei T, Nakayama H, Motoi N, Urano S, Eda R, Yokoba M, Tsuchihashi Y, Nasuhara Y, Ishii H, Ebina M, Yamaguchi E, Inoue Y, Nakata K, Tazawa R.

Eur Respir J. 2012 Mar;39(3):777-80. doi: 10.1183/09031936.00076711. No abstract available.

25.

[A case of systemic IgG4-related disease with a middle-posterior mediastinal lesion].

Maki S, Takakura A, Hiyoshi Y, Yokoba M, Masuda N, Katagiri M.

Nihon Kokyuki Gakkai Zasshi. 2011 Dec;49(12):908-12. Japanese.

PMID:
22352051
26.

Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer.

Wada M, Yamamoto M, Ryuge S, Nagashima Y, Hayashi N, Maki S, Otani S, Katono K, Takakura A, Yanaihara T, Igawa S, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Masuda N.

Cancer Chemother Pharmacol. 2012 Apr;69(4):1005-11. doi: 10.1007/s00280-011-1795-5. Epub 2011 Dec 8.

PMID:
22160350
27.

Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.

Ohashi K, Sato A, Takada T, Arai T, Nei T, Kasahara Y, Motoi N, Hojo M, Urano S, Ishii H, Yokoba M, Eda R, Nakayama H, Nasuhara Y, Tsuchihashi Y, Kaneko C, Kanazawa H, Ebina M, Yamaguchi E, Kirchner J, Inoue Y, Nakata K, Tazawa R.

Respir Med. 2012 Feb;106(2):284-93. doi: 10.1016/j.rmed.2011.10.019. Epub 2011 Nov 22.

28.

Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.

Tazawa R, Trapnell BC, Inoue Y, Arai T, Takada T, Nasuhara Y, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ishii H, Yokoba M, Tanaka N, Yamaguchi E, Eda R, Tsuchihashi Y, Morimoto K, Akira M, Terada M, Otsuka J, Ebina M, Kaneko C, Nukiwa T, Krischer JP, Akazawa K, Nakata K.

Am J Respir Crit Care Med. 2010 Jun 15;181(12):1345-54. doi: 10.1164/rccm.200906-0978OC. Epub 2010 Feb 18.

29.

Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan.

Ryuge S, Jiang SX, Wada M, Katono K, Iwasaki M, Takakura A, Otani S, Kimura Y, Fukui T, Yokoba M, Kubota M, Katagiri M, Hayakawa K, Masuda N.

Drug Des Devel Ther. 2009 Sep 21;3:213-7.

30.

Parasternal muscle activity decreases in severe COPD with salmeterol-fluticasone propionate.

Easton PA, Hawes HG, Doig CJ, Johnson MW, Yokoba M, Wilde ER.

Chest. 2010 Mar;137(3):558-65. doi: 10.1378/chest.09-0197. Epub 2009 Oct 9.

PMID:
19820074
31.

Effect of gefitinib on warfarin antithrombotic activity.

Arai S, Mitsufuji H, Nishii Y, Onoda S, Ryuge S, Wada M, Katono K, Iwasaki M, Takakura A, Otani S, Yamamoto M, Yanaihara T, Yokoba M, Kubota M, Katagiri M, Fukui T, Kobayashi H, Yanase N, Hataishi R, Masuda N.

Int J Clin Oncol. 2009 Aug;14(4):332-6. doi: 10.1007/s10147-008-0871-2. Epub 2009 Aug 25.

PMID:
19705244
32.

Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in rats.

Yamamoto M, Kurita A, Asahara T, Takakura A, Katono K, Iwasaki M, Ryuge S, Wada M, Onoda S, Yanaihara T, Yokoba M, Mitsufuji H, Nishii Y, Fukui T, Masuda N.

Oncol Rep. 2008 Oct;20(4):727-30.

PMID:
18813810
33.

Aminophylline increases parasternal intercostal muscle activity during hypoxia in humans.

Nishii Y, Okada Y, Yokoba M, Katagiri M, Yanaihara T, Masuda N, Easton PA, Abe T.

Respir Physiol Neurobiol. 2008 Mar 20;161(1):69-75. doi: 10.1016/j.resp.2007.12.004. Epub 2007 Dec 23.

PMID:
18243069
34.

[Recurrent pulmonary edema associated with obstructive sleep apnea syndrome].

Yanaihara T, Yokoba M, Kubota M, Nishii Y, Miyamoto M, Abe T, Masuda N, Katagiri M.

Nihon Kokyuki Gakkai Zasshi. 2006 Nov;44(11):812-6. Japanese.

PMID:
17144578
35.

Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.

Onoda S, Masuda N, Seto T, Eguchi K, Takiguchi Y, Isobe H, Okamoto H, Ogura T, Yokoyama A, Seki N, Asaka-Amano Y, Harada M, Tagawa A, Kunikane H, Yokoba M, Uematsu K, Kuriyama T, Kuroiwa Y, Watanabe K; Thoracic Oncology Research Group Study 0301.

J Clin Oncol. 2006 Dec 1;24(34):5448-53.

PMID:
17135647
36.

Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer.

Yanaihara T, Yokoba M, Onoda S, Yamamoto M, Ryuge S, Hagiri S, Katagiri M, Wada M, Mitsufuji H, Kubota M, Arai S, Kobayashi H, Yanase N, Abe T, Masuda N.

Cancer Chemother Pharmacol. 2007 Mar;59(4):419-27. Epub 2006 Jul 11.

PMID:
16832665
37.

Drug interaction between gefitinib and warfarin.

Onoda S, Mitsufuji H, Yanase N, Ryuge S, Kato E, Wada M, Ishii K, Hagiri S, Yamamoto M, Yokoba M, Yanaihara T, Kuboto M, Takada N, Katagiri M, Abe T, Tanaka N, Kobayashi H, Masuda N.

Jpn J Clin Oncol. 2005 Aug;35(8):478-82. Epub 2005 Jul 8.

PMID:
16006576
38.

[New anti-cancer agents--from cytotoxic systemic chemotherapy to target-based agents].

Yokoba M, Yanase N, Masuda N.

Gan To Kagaku Ryoho. 2005 Jun;32(6):783-8. Review. Japanese.

PMID:
15984516
39.

Neck and abdominal muscle activity during a sniff.

Katagiri M, Abe T, Yokoba M, Dobashi Y, Tomita T, Easton PA.

Respir Med. 2003 Sep;97(9):1027-35.

40.

Respiratory muscle electromyogram and mouth pressure during isometric contraction.

Yokoba M, Abe T, Katagiri M, Tomita T, Easton PA.

Respir Physiol Neurobiol. 2003 Aug 14;137(1):51-60.

PMID:
12871677
41.

[Electromyographic activity of human triangularis sterni muscles during thoracic rotation].

Kobayashi C, Namai S, Katagiri M, Yokoba M, Abe T.

Nihon Kokyuki Gakkai Zasshi. 2003 Feb;41(2):138-43. Japanese.

PMID:
12722335
42.

Geniohyoid muscle function in awake canines.

Yokoba M, Hawes HG, Easton PA.

J Appl Physiol (1985). 2003 Aug;95(2):810-7. Epub 2003 Apr 4.

43.

[Relation between neck accessory inspiratory muscle electromyographic activity and lung volume].

Masubuchi Y, Abe T, Yokoba M, Yamada T, Katagiri M, Tomita T.

Nihon Kokyuki Gakkai Zasshi. 2001 Apr;39(4):244-9. Japanese.

PMID:
11481822
44.

[Postural effects on electromyographic activity of the transversus abdominis muscle].

Yamada T, Abe T, Katagiri M, Yokoba M, Dobashi Y, Tomita T.

Nihon Kokyuki Gakkai Zasshi. 2000 Feb;38(2):100-6. Japanese.

PMID:
10774167
45.

[Electromyographic activity of neck muscles during the production of inspiratory pressure].

Yokoba M, Abe T, Katagiri M, Dobashi Y, Yamada T, Tomita T.

Nihon Kokyuki Gakkai Zasshi. 1999 Feb;37(2):102-7. Japanese.

PMID:
10214037
46.

[Effects of uvulopalatopharyngoplasty on patients with obstructive sleep apnea--the severity of preoperative tonsillar hypertrophy].

Fukuda N, Abe T, Katagiri M, Yokoba M, Okamoto M, Tomita T.

Nihon Kokyuki Gakkai Zasshi. 1998 Jan;36(1):34-40. Japanese.

PMID:
9611974
47.

[A case of severe acute hepatorenal failure due to Aeromoas hydrophila septicemia].

Yokoba M, Shirasaki K, Aoki N, Soma K.

Kansenshogaku Zasshi. 1996 Oct;70(10):1111-5. Japanese.

PMID:
8952274
48.

[Pulmonary tuberculosis manifesting predominantly as ileus secondary to peritoneal tuberculosis in a young man].

Yokoba M, Takahashi T, Yosii A, Kitsuda T, Bessho T, Misu Y, Tomita T.

Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Apr;34(4):487-93. Japanese.

PMID:
8691674

Supplemental Content

Loading ...
Support Center